市場調査レポート

商品コード

1701723

臨床試験の市場規模、シェア、成長分析、サービスタイプ別、フェーズ別、モダリティ別、治療領域別、デリバリーモデル別、地域別 - 産業予測 2025～2032年

Clinical Trials Market Size, Share, and Growth Analysis, By Service Type, By Phase, By Modality, By Therapeutic Area, By Delivery Model, By Region - Industry Forecast 2025-2032

出版日: 2025年04月05日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 774,224円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 905,696円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,037,168円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.08円

全表示
概要
目次

概要

サンプル依頼リストに入れる

臨床試験市場規模は2023年に813億米ドルと評価され、予測期間（2025-2032年）のCAGRは6.5%で、2024年の865億8,000万米ドルから2032年には1,433億米ドルに成長する見通しです。

臨床試験市場は、新興市場における臨床試験の増加、製薬企業による研究開発投資の活発化、疾患、特に希少疾患や希少疾病の有病率の上昇など、さまざまな要因によって大きな成長を遂げています。糖尿病のような疾患は、2021年には20歳から79歳の推定患者数が5億3,660万人に達し、2045年には7億8,370万人に増加する可能性があるため、革新的な治療法に対する需要が高まっています。さらに、2022年1月に開始された欧州委員会の「EUにおける研究加速化プログラム（Accelerating臨床試験）」のような政府のイニシアチブは、臨床試験のプロセスを合理化し、臨床研究のハブとしての欧州の地位を高めることを目的としています。このような支援環境が世界産業の成長を後押しし、安全で効果的な医薬品開発の進歩を促進しています。

市場概要
臨床試験の管理とモニタリング
ラボサービス
- 分析試験サービス
- 生体分析試験サービス
臨床試験データ管理サービス
- 生物統計学
- その他のデータ管理サービス
臨床試験の供給と物流サービス
コンサルティング
患者の募集と維持
メディカルライティング
安全性と医薬品安全性監視
その他のサービスタイプ

臨床試験市場規模：フェーズ別& CAGR（2025-2032）

市場概要
フェーズIII
フェーズII
フェーズI
フェーズIV

臨床試験市場規模：モダリティ別& CAGR（2025-2032）

市場概要
小分子
生物学的製剤
医療機器および体外診断用医薬品

臨床試験市場規模：治療領域別& CAGR（2025-2032）

市場概要
腫瘍学
神経学
呼吸器疾患
代謝疾患/内分泌学
心血管系疾患
皮膚科
消化器疾患
免疫疾患
感染症
精神医学
眼科
血液学
泌尿生殖器と女性の健康
その他の治療領域

臨床試験市場規模：デリバリーモデル別& CAGR（2025-2032）

市場概要
フルサービスアウトソーシング（FSO）モデル
機能サービスプロバイダー（FSP）モデル
ハイブリッドモデル

臨床試験市場規模：研究デザイン別& CAGR（2025-2032）

市場概要
介入的
観察的

臨床試験市場規模：エンドユーザー別& CAGR（2025-2032）

市場概要
製薬・バイオ医薬品企業
医療機器企業
学術機関

臨床試験市場規模：地域別& CAGR（2025-2032）

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
最近の市場動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 企業の詳細
- 製品ポートフォリオ分析
- 企業のセグメント別シェア分析
- 収益の前年比比較（2022-2024年）

主要企業プロファイル

Thermo Fisher Scientific, Inc.（US）
IQVIA, Inc.（US）
ICON plc（Ireland）
Laboratory Corporation of America Holdings（US）
Syneos Health（US）
Charles River Laboratories（US）
Fortrea, Inc.（US）
SGS（Switzerland）
ACM Global Laboratories（US）
Advanced Clinical（US）
PSI（Switzerland）
BioAgile（India）
Pepgra（India）
CTI Clinical Trial and Consulting Services（US）
Dove Quality Solutions（UK）
Firma Clinical Research（US）

結論と提言

Product Code: SQMIG35A2641

Clinical Trials Market size was valued at USD 81.3 billion in 2023 and is poised to grow from USD 86.58 billion in 2024 to USD 143.3 billion by 2032, growing at a CAGR of 6.5% during the forecast period (2025-2032).

The Clinical Trials Market is experiencing significant growth driven by various factors, including increased clinical trials in emerging markets, heightened R&D investment by pharmaceutical companies, and the rising prevalence of diseases, especially rare and orphan diseases. Conditions such as diabetes, which affected an estimated 536.6 million individuals aged 20 to 79 in 2021 and may rise to 783.7 million by 2045, are intensifying the demand for innovative therapies. Additionally, government initiatives, like the European Commission's Accelerating Clinical Trials in the EU program launched in January 2022, aim to streamline trial processes and enhance Europe's standing as a hub for clinical research. This supportive environment bolsters global industry growth, driving advancements in safe and effective pharmaceutical development.

Top-down and bottom-up approaches were used to estimate and validate the size of the Clinical Trials market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Clinical Trials Market Segments Analysis

Global Clinical Trials Market is segmented by Service Type, Phase, Modality, Therapeutic Area, Delivery Model, Study Design, End User and region. Based on Service Type, the market is segmented into Clinical Trial Management & Monitoring, Laboratory Services, Clinical Trial Data Management Services, Clinical Trial Supply & Logistic Services, Consulting, Patient Recruitment & Retention, Medical Writing, Safety & Pharmacovigilance and Other Service Types. Based on Phase, the market is segmented into Phase III, Phase II, Phase I and Phase IV. Based on Modality, the market is segmented into Small Molecules, Biologics and Medical Devices & IVD. Based on Therapeutic Area, the market is segmented into Oncology, Neurology, Respiratory Disorders, Metabolic Disorders/Endocrinology, Cardiovascular System Disorders, Dermatology, Gastrointestinal Diseases, Immunological Disorders, Infectious Diseases, Psychiatry, Ophthalmology, Hematology, Genitourinary & Women's Health and Other Therapeutic Areas. Based on Delivery Model, the market is segmented into Full-Service Outsourcing (FSO) Model, Functional Service Provider (FSP) Model and Hybrid Model. Based on Study Design, the market is segmented into Interventional and Observational. Based on End User, the market is segmented into Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Clinical Trials Market

The growth of the Clinical Trials market is significantly propelled by increased investments in research and development by biotechnology and pharmaceutical companies. To successfully develop and launch new therapies, these organizations must meticulously design clinical trials. A surge in both public and private funding enables them to implement larger-scale research projects that enhance the safety and efficacy evaluations of new drugs. Such financial backing expedites the medication approval process and ultimately improves patient access to innovative treatments. Additionally, this investment fosters the discovery of new therapies while elevating the standards of clinical research, thus driving overall market growth.

Restraints in the Clinical Trials Market

Regulatory challenges significantly hinder the clinical trials market, often causing substantial delays in research and development due to difficulties in obtaining necessary approvals. Regulatory bodies like the FDA and EMA impose stringent requirements that necessitate meticulous documentation and adherence to Good Clinical Practice (GCP), along with comprehensive safety measures. These stringent regulations can be particularly burdensome for smaller firms, which may be deterred from initiating clinical studies due to the high costs associated with regulatory compliance. Additionally, varying national regulations in multi-national trials complicate the process further, slowing progress and limiting access to a diverse range of patient populations.

Market Trends of the Clinical Trials Market

The clinical trials market is witnessing a significant shift towards decentralized clinical trials (DCTs), driven by advancements in technology that enable virtual participation and remote patient monitoring. This trend enhances accessibility and flexibility for participants, ultimately fostering higher engagement through the use of wearable devices, telemedicine, and mobile health applications. As DCTs reduce travel-related costs and streamline data collection, they facilitate more efficient patient recruitment and retention, thereby expediting the overall clinical trial process. This evolution not only promises improved patient experiences but also holds the potential to transform the landscape of clinical research, making it more adaptive to modern healthcare needs.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Analysis
Technology Analysis
Case Studies

Global Clinical Trials Market Size by Service Type & CAGR (2025-2032)

Market Overview
Clinical Trial Management & Monitoring
Laboratory Services
- Analytical Testing Services
- Bioanalytical Testing Services
Clinical Trial Data Management Services
- Biostatistics
- Other Data Management Services
Clinical Trial Supply & Logistic Services
Consulting
Patient Recruitment & Retention
Medical Writing
Safety & Pharmacovigilance
Other Service Types

Global Clinical Trials Market Size by Phase & CAGR (2025-2032)

Market Overview
Phase III
Phase II
Phase I
Phase IV

Global Clinical Trials Market Size by Modality & CAGR (2025-2032)

Market Overview
Small Molecules
Biologics
Medical Devices & IVD

Global Clinical Trials Market Size by Therapeutic Area & CAGR (2025-2032)

Market Overview
Oncology
Neurology
Respiratory Disorders
Metabolic Disorders/Endocrinology
Cardiovascular System Disorders
Dermatology
Gastrointestinal Diseases
Immunological Disorders
Infectious Diseases
Psychiatry
Ophthalmology
Hematology
Genitourinary & Women's Health
Other Therapeutic Areas

Global Clinical Trials Market Size by Delivery Model & CAGR (2025-2032)

Market Overview
Full-Service Outsourcing (FSO) Model
Functional Service Provider (FSP) Model
Hybrid Model

Global Clinical Trials Market Size by Study Design & CAGR (2025-2032)

Market Overview
Interventional
Observational

Global Clinical Trials Market Size by End User & CAGR (2025-2032)

Market Overview
Pharmaceutical & Biopharmaceutical Companies
Medical Device Companies
Academic Institutes

Global Clinical Trials Market Size & CAGR (2025-2032)

North America (Service Type, Phase, Modality, Therapeutic Area, Delivery Model, Study Design, End User)
- US
- Canada
Europe (Service Type, Phase, Modality, Therapeutic Area, Delivery Model, Study Design, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Service Type, Phase, Modality, Therapeutic Area, Delivery Model, Study Design, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Service Type, Phase, Modality, Therapeutic Area, Delivery Model, Study Design, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Service Type, Phase, Modality, Therapeutic Area, Delivery Model, Study Design, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Thermo Fisher Scientific, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IQVIA, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ICON plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Laboratory Corporation of America Holdings (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Syneos Health (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Charles River Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fortrea, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SGS (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ACM Global Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Advanced Clinical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PSI (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioAgile (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pepgra (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CTI Clinical Trial and Consulting Services (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dove Quality Solutions (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Firma Clinical Research (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments